Tics Moderate Sertraline, but Not Cognitive-Behavior Therapy Response in Pediatric Obsessive-Compulsive Disorder Patients Who Do Not Respond to Cognitive-Behavior Therapy.

Journal Article (Journal Article;Multicenter Study)

OBJECTIVE: The purpose of this study was to investigate whether the presence of tic disorder is negatively associated with sertraline (SRT) outcomes, but not with continued cognitive-behavioral therapy (CBT), in a sample of youth who were unresponsive to an initial full course of CBT. METHODS: In the Nordic Long-Term OCD Study, children and adolescents with OCD who were rated as nonresponders to 14 weeks of open-label CBT were randomized to continued CBT (n=28) or SRT treatment (n=22) for an additional 16 weeks of treatment. We investigated whether the presence or absence of comorbid tic disorder moderated treatment outcomes on the Children's Yale-Brown Obsessive Compulsive Scale (CY-BOCS). RESULTS: Twelve out of 50 (24.0%) participants were diagnosed with comorbid tic disorder, with 7 receiving continued CBT and 5 receiving SRT, respectively. In patients without tic disorder, results showed no significant between-group differences on average CY-BOCS scores. However, in patients with comorbid tic disorder, those who received SRT had significantly lower average CY-BOCS scores than those who received continued CBT. CONCLUSIONS: Children and adolescents with OCD and comorbid tic disorder, who are nonresponders to an initial 14 week course of CBT, may benefit more from a serotonin reuptake inhibitor (SRI) than from continued CBT.

Full Text

Duke Authors

Cited Authors

  • Skarphedinsson, G; Compton, S; Thomsen, PH; Weidle, B; Dahl, K; Nissen, JB; Torp, NC; Hybel, K; Melin, KH; Valderhaug, R; Wentzel-Larsen, T; Ivarsson, T

Published Date

  • June 2015

Published In

Volume / Issue

  • 25 / 5

Start / End Page

  • 432 - 439

PubMed ID

  • 26091197

Pubmed Central ID

  • PMC4491151

Electronic International Standard Serial Number (EISSN)

  • 1557-8992

Digital Object Identifier (DOI)

  • 10.1089/cap.2014.0167


  • eng

Conference Location

  • United States